{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T19:35:28Z","timestamp":1772998528381,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T00:00:00Z","timestamp":1517356800000},"content-version":"vor","delay-in-days":30,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior Case Reports"],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/j.ebcr.2018.01.002","type":"journal-article","created":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T03:49:48Z","timestamp":1518061788000},"page":"8-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Drug-resistant epilepsy development following stem cell transplant and cyclosporine neurotoxicity induced seizures: Case report in an adult and analysis of reported cases in the literature"],"prefix":"10.1016","volume":"10","author":[{"given":"Adam S.","family":"Vesole","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunori","family":"Nagahama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Granner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew A.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroto","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Dlouhy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.ebcr.2018.01.002_bb0005","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM198912213212507","article-title":"Cyclosporine","volume":"321","author":"Kahan","year":"1989","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ebcr.2018.01.002_bb0010","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s004150050360","article-title":"Cyclosporine neurotoxicity: a review","volume":"246","author":"Gijtenbeek","year":"1999","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.ebcr.2018.01.002_bb0015","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.arcmed.2006.07.005","article-title":"Severe neurological events following liver transplantation","volume":"38","author":"Saner","year":"2007","journal-title":"Arch Med Res"},{"issue":"10","key":"10.1016\/j.ebcr.2018.01.002_bb0020","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/sj.bmt.1704023","article-title":"Mesial temporal sclerosis\u2014a late complication in four allogeneic pediatric recipients with persistent seizures after an acute episode of cyclosporine-A neurotoxicity","volume":"31","author":"Faraci","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.ebcr.2018.01.002_bb0025","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ejpn.2016.04.007","article-title":"Epilepsy surgery in a liver-transplanted girl with temporal lobe epilepsy and hippocampal sclerosis following PRES with status epilepticus","volume":"20","author":"Dilena","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"issue":"5","key":"10.1016\/j.ebcr.2018.01.002_bb0030","first-page":"393","article-title":"Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin","volume":"8","author":"Reece","year":"1991","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.ebcr.2018.01.002_bb0035","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1034\/j.1600-0609.2001.t01-1-00440.x","article-title":"Clinical findings and magnetic resonance imaging in severe cyclosporine-related neurotoxicity after allogeneic bone marrow transplantation","volume":"67","author":"Trullemans","year":"2001","journal-title":"Eur J Haematol"},{"issue":"12","key":"10.1016\/j.ebcr.2018.01.002_bb0040","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1136\/jnnp.53.12.1068","article-title":"Cyclosporin-associated akinetic mutism and extrapyramidal syndrome after liver transplantation","volume":"53","author":"Bird","year":"1990","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"24","key":"10.1016\/j.ebcr.2018.01.002_bb0045","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1056\/NEJM199106133242417","volume":"324","year":"1991","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ebcr.2018.01.002_bb0050","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1177\/08830738060210100501","article-title":"Intractable epilepsy secondary to cyclosporine toxicity in children undergoing allogeneic hematopoietic bone marrow transplantation","volume":"21","author":"Gaggero","year":"2006","journal-title":"J Child Neurol"},{"issue":"7","key":"10.1016\/j.ebcr.2018.01.002_bb0055","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1177\/088307389801300706","article-title":"Cyclosporin A acute encephalopathy and seizure syndrome in childhood: clinical features and risk of seizure recurrence","volume":"13","author":"Gleeson","year":"1998","journal-title":"J Child Neurol"},{"issue":"6471","key":"10.1016\/j.ebcr.2018.01.002_bb0060","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1136\/bmj.290.6471.858-a","article-title":"Convulsions associated with cyclosporin A","volume":"290","author":"O'Sullivan","year":"1985","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"2","key":"10.1016\/j.ebcr.2018.01.002_bb0065","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/PEC.0b013e3182442fe8","article-title":"Posterior reversible encephalopathy syndrome in childhood: report of four cases and review of the literature","volume":"28","author":"Endo","year":"2012","journal-title":"Pediatr Emerg Care"},{"issue":"2","key":"10.1016\/j.ebcr.2018.01.002_bb0070","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/pbc.21211","article-title":"In cyclosporine induced neurotoxicity, is tacrolimus an appropriate substitute or is it out of the frying pan and into the fire?","volume":"50","author":"Ayas","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.ebcr.2018.01.002_bb0075","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ejpn.2015.02.003","article-title":"Age-dependent vulnerability of cyclosporine-associated encephalopathy in children","volume":"19","author":"Chen","year":"2015","journal-title":"Eur J Paediatr Neurol"},{"issue":"4","key":"10.1016\/j.ebcr.2018.01.002_bb0080","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/j.1875-9114.1996.tb03639.x","article-title":"Cyclosporine neurotoxicity","volume":"16","author":"Hauben","year":"1996","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1016\/j.ebcr.2018.01.002_bb0085","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s11596-013-1176-x","article-title":"Analysis of seizure risk factors after allogeneic hematopoietic stem cell transplantation: a 8 case report and literature review","volume":"33","author":"Zhong","year":"2013","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"10.1016\/j.ebcr.2018.01.002_bb0090","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.yebeh.2015.09.027","article-title":"Predicting drug resistance in adult patients with generalized epilepsy: a case\u2013control study","volume":"53","author":"Voll","year":"2015","journal-title":"Epilepsy Behav"},{"issue":"9","key":"10.1016\/j.ebcr.2018.01.002_bb0095","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/j.1528-1167.2012.03562.x","article-title":"Predictors and course of medically intractable epilepsy in young children presenting before 36months of age: a retrospective, population-based study","volume":"53","author":"Wirrell","year":"2012","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.ebcr.2018.01.002_bb0100","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.pediatrneurol.2012.09.008","article-title":"Predictors of intractable childhood epilepsy","volume":"48","author":"Seker Yilmaz","year":"2013","journal-title":"Pediatr Neurol"},{"issue":"1","key":"10.1016\/j.ebcr.2018.01.002_bb0105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1212\/WNL.46.1.41","article-title":"Does the number of seizures before treatment influence ease of control or remission of childhood epilepsy? Not if the number is 10 or less","volume":"46","author":"Camfield","year":"1996","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ebcr.2018.01.002_bb0110","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1542\/peds.2012-1420","article-title":"Temporal lobe epilepsy with hippocampal sclerosis in acute lymphoblastic leukemia","volume":"132","author":"Kasai-Yoshida","year":"2013","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.ebcr.2018.01.002_bb0115","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s15010-015-0822-6","article-title":"Chronic herpes simplex type-1 encephalitis with intractable epilepsy in an immunosuppressed patient","volume":"44","author":"Laohathai","year":"2016","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.ebcr.2018.01.002_bb0120","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/ctr.12000","article-title":"Epileptic seizures in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors, and survival rates","volume":"27","author":"Zhang","year":"2013","journal-title":"Clin Transpl"},{"issue":"6","key":"10.1016\/j.ebcr.2018.01.002_bb0125","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.0013-9580.2004.09004.x","article-title":"ILAE commission report. Mesial temporal lobe epilepsy with hippocampal sclerosis","volume":"45","author":"Wieser","year":"2004","journal-title":"Epilepsia"},{"issue":"Suppl. 3","key":"10.1016\/j.ebcr.2018.01.002_bb0130","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1528-1167.2011.03031.x","article-title":"Autoantibodies and epilepsy","volume":"52","author":"Bien","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebcr.2018.01.002_bb0135","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.yebeh.2015.11.021","article-title":"A population-based study of active and drug-resistant epilepsies in Northern Italy","volume":"55","author":"Giussani","year":"2016","journal-title":"Epilepsy Behav"},{"issue":"10","key":"10.1016\/j.ebcr.2018.01.002_bb0140","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMra1004418","article-title":"Drug-resistant epilepsy","volume":"365","author":"Kwan","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ebcr.2018.01.002_bb0145","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.nurt.2006.11.010","article-title":"Molecular targets for antiepileptic drug development","volume":"4","author":"Meldrum","year":"2007","journal-title":"Neurotherapeutics"},{"issue":"6","key":"10.1016\/j.ebcr.2018.01.002_bb0150","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/lt.500030603","article-title":"Neoral in de novo liver transplantation: adequate immunosuppression without intravenous cyclosporine","volume":"3","author":"Levy","year":"1997","journal-title":"Liver Transpl Surg"},{"issue":"12","key":"10.1016\/j.ebcr.2018.01.002_bb0155","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1097\/00007890-199612270-00020","article-title":"A microemulsion of cyclosporine without intravenous cyclosporine in liver transplantation","volume":"62","author":"Hemming","year":"1996","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.ebcr.2018.01.002_bb0160","article-title":"Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients","author":"Webster","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.ebcr.2018.01.002_bb0165","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1432-2277.2000.tb01004.x","article-title":"Neurotoxicity of calcineurin inhibitors: impact and clinical management","volume":"13","author":"Bechstein","year":"2000","journal-title":"Transpl Int"},{"issue":"12","key":"10.1016\/j.ebcr.2018.01.002_bb0170","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/sj.bmt.1703076","article-title":"Mycophenolate mofetil for the prevention and treatment of graft-versus-host disease following stem cell transplantation: preliminary findings","volume":"27","author":"Vogelsang","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.ebcr.2018.01.002_bb0175","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.transproceed.2014.11.005","article-title":"Everolimus plus mycophenolate mofetil as initial immunosuppression in liver transplantation","volume":"47","author":"Jimenez-Perez","year":"2015","journal-title":"Transplant Proc"},{"issue":"5","key":"10.1016\/j.ebcr.2018.01.002_bb0180","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1212\/WNL.51.5.1256","article-title":"Is the underlying cause of epilepsy a major prognostic factor for recurrence?","volume":"51","author":"Semah","year":"1998","journal-title":"Neurology"}],"container-title":["Epilepsy & Behavior Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213323218300033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213323218300033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T01:49:50Z","timestamp":1719798590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213323218300033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":36,"alternative-id":["S2213323218300033"],"URL":"https:\/\/doi.org\/10.1016\/j.ebcr.2018.01.002","relation":{},"ISSN":["2213-3232"],"issn-type":[{"value":"2213-3232","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-resistant epilepsy development following stem cell transplant and cyclosporine neurotoxicity induced seizures: Case report in an adult and analysis of reported cases in the literature","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebcr.2018.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}